Determination of “indeterminate score” measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia

Table 2 Frequency of demographic features, metabolic diseases and noninvasive fibrosis assessment findings in the study cohort

Variable	Lean	Overweight	Obese	P1
Sex				0.002
Female	61 (38.4%)	142 (38.9%)	359 (48.7%)
Male	98 (61.6%)	223 (61.1%)	378 (51.3%)
Hyperlipidaemia				< 0.001
Absent	76 (47.8%)	130 (35.6%)	235 (31.9%)
Present	76 (47.8%)	205 (56.2%)	457 (62.0%)
DM				< 0.001
Non-diabetic	103 (64.8%)	171 (46.8%)	294 (39.9%)
Diabetic	50 (31.4%)	171 (46.8%)	405 (55.0%)
HTN				0.002
Normotensive	103 (64.8%)	198 (54.2%)	366 (49.7%)
Hypertensive	50 (31.4%)	144 (39.5%)	333 (45.2%)
NFS reference				< 0.001
F0-F2	85 (53.5%)	173 (47.4%)	256 (34.7%)
F3-F4	5 (3.1%)	16 (4.4%)	84 (11.4%)
Indeterminate score	30 (18.9%)	89 (24.4%)	237 (32.2%)

¹Comparison was done using chi-square test of significance, with P-value of < 0.05 indicating statistical significance. DM: Diabetes mellitus; HTN: Hypertension; NFS: Nonalcoholic fatty liver disease fibrosis score.